Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bovine Lactoferrin for Neonatal Infection Prevention in LBW Babies
NCT03431558Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of bovine lactoferrin in neonatal sepsis, necrotizing enterocolitis (NEC), sponsored by Aga Khan University. Status: unknown.
02
Drugs
bovine lactoferrin
03
Conditions
neonatal sepsisnecrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT03431558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431558.